BIONET Corp. (TPEX:1784)
Taiwan · Delayed Price · Currency is TWD 79.50
-1.50 (-1.85%)
At close: Mar 27, 2026
BIONET Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 51.43 | 83.7 | 78.4 | 37.97 | 26.62 |
Depreciation & Amortization | 62.33 | 38.36 | 32.28 | 34.38 | 31.16 |
Other Amortization | - | 7.2 | 7.32 | 8.67 | 7.68 |
Loss (Gain) From Sale of Assets | -0.02 | -0.39 | -0 | -0.01 | 0.03 |
Loss (Gain) From Sale of Investments | -1.56 | -2.33 | -2.63 | 5.35 | -0.21 |
Stock-Based Compensation | 24.42 | 26.25 | 4.99 | - | 2.44 |
Provision & Write-off of Bad Debts | 2.36 | 0.6 | 1.6 | 3.14 | 0.33 |
Other Operating Activities | -75.91 | -21.39 | 19.48 | 25.28 | 12.3 |
Change in Accounts Receivable | 53.9 | 27.23 | -30.56 | -67.44 | -74.97 |
Change in Inventory | -44.52 | -25.8 | -8.84 | 32.65 | 1.02 |
Change in Accounts Payable | 16.13 | -4.29 | 9.74 | 1.34 | 19.94 |
Change in Unearned Revenue | 58.85 | 62.92 | 37.35 | 23.33 | 2.32 |
Change in Other Net Operating Assets | -6.57 | 5.99 | 14.87 | 29.83 | -17.58 |
Operating Cash Flow | 148.04 | 176.49 | 153.1 | 94.65 | 13.88 |
Operating Cash Flow Growth | -16.12% | 15.28% | 61.74% | 582.04% | -81.16% |
Capital Expenditures | -123.62 | -101.35 | -20.04 | -28.87 | -10.17 |
Sale of Property, Plant & Equipment | 0.45 | 0.39 | 0 | 0.01 | - |
Sale (Purchase) of Intangibles | -8.56 | -2.14 | -6.24 | -4.04 | -6.49 |
Investment in Securities | 170.33 | -668.79 | -383.26 | 30.43 | 13.14 |
Other Investing Activities | -3.23 | -6.26 | -0.39 | -0.44 | -1.06 |
Investing Cash Flow | 35.37 | -778.15 | -409.93 | -2.91 | -4.59 |
Short-Term Debt Issued | 90 | 35 | 30 | - | - |
Total Debt Issued | 90 | 35 | 30 | - | - |
Short-Term Debt Repaid | -85 | - | - | - | - |
Long-Term Debt Repaid | -13.11 | -10.97 | -8.03 | -7.61 | -7.1 |
Total Debt Repaid | -98.11 | -10.97 | -8.03 | -7.61 | -7.1 |
Net Debt Issued (Repaid) | -8.11 | 24.03 | 21.97 | -7.61 | -7.1 |
Issuance of Common Stock | 6.96 | 13.99 | 6.7 | - | 7.18 |
Repurchase of Common Stock | -61.94 | -40.71 | - | -41.25 | -6.66 |
Common Dividends Paid | -70.06 | -33.15 | -32.63 | -23.52 | -8.77 |
Other Financing Activities | -36.8 | 641.29 | 337.93 | 20.48 | -0.25 |
Financing Cash Flow | -169.96 | 605.46 | 333.98 | -51.9 | -15.6 |
Foreign Exchange Rate Adjustments | -0.2 | 0.49 | -0.27 | -0.03 | -0.26 |
Net Cash Flow | 13.26 | 4.3 | 76.88 | 39.82 | -6.56 |
Free Cash Flow | 24.42 | 75.15 | 133.05 | 65.78 | 3.71 |
Free Cash Flow Growth | -67.51% | -43.52% | 102.27% | 1674.48% | -92.08% |
Free Cash Flow Margin | 1.98% | 6.15% | 11.80% | 6.71% | 0.40% |
Free Cash Flow Per Share | 0.48 | 1.48 | 2.63 | 1.30 | 0.07 |
Cash Interest Paid | 1.5 | 1.28 | 0.41 | 0.46 | 0.39 |
Cash Income Tax Paid | 44.32 | 34.12 | 9.06 | 6.75 | 3.48 |
Levered Free Cash Flow | -98.61 | -23.02 | 70.21 | 32 | 135.63 |
Unlevered Free Cash Flow | -97.67 | -22.23 | 70.47 | 32.29 | 135.87 |
Change in Working Capital | 84.99 | 44.49 | 11.65 | -20.14 | -66.47 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.